Stay updated on Long Term Safety of Serlopitant for Pruritus Clinical Trial
Sign up to get notified when there's something new on the Long Term Safety of Serlopitant for Pruritus Clinical Trial page.

Latest updates to the Long Term Safety of Serlopitant for Pruritus Clinical Trial page
- CheckyesterdayChange DetectedThe Locations section now includes a broad list of U.S. study sites (Alabama, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Michigan, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia). The page revision tag changed from v3.3.2 to v3.3.3.SummaryDifference2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check36 days agoChange DetectedRemoval of the government funding status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedNo substantive changes to the study details were detected; any observed differences are limited to formatting or rendering.SummaryDifference0.2%

- Check79 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

- Check86 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; old revision tag removed and new revision tag added.SummaryDifference0.1%

Stay in the know with updates to Long Term Safety of Serlopitant for Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Safety of Serlopitant for Pruritus Clinical Trial page.